What's new in prostate cancer screening and prevention?

被引:6
作者
Klein, Eric A. [1 ,2 ]
机构
[1] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
关键词
TRIAL; ANTIGEN; RISK; MEN; MORTALITY;
D O I
10.3949/ccjm.76a.02009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prostate cancer is extremely common but causes death in only a minority of men in whom it develops, facts that raise issues regarding screening and treatment morbidity. Two large trials of screening with prostate-specific antigen (PSA) measurements came to seemingly opposite conclusions. Furthermore; a large trial of selenium and vitamin E found that these agents have no value as preventive agents.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 22 条
  • [1] FURTHER ANALYSES FROM THE REDUCE PROSTATE CANCER RISK REDUCTION TRIAL
    Andriole, Gerald
    Bostwick, David
    Brawley, Otis
    Gomella, Leonard
    Marberger, Michael
    Montorsi, Francesco
    Pettaway, Curtis
    Tammela, Teuvo
    Teloken, Claudio
    Tindall, Donald
    Teloken, Claudio
    Tindall, Donald
    Somerville, Matthew
    Rittmaster, Roger
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04) : 555 - 555
  • [2] Mortality Results from a Randomized Prostate-Cancer Screening Trial
    Andriole, Gerald L.
    Grubb, Robert L., III
    Buys, Saundra S.
    Chia, David
    Church, Timothy R.
    Fouad, Mona N.
    Gelmann, Edward P.
    Kvale, Paul A.
    Reding, Douglas J.
    Weissfeld, Joel L.
    Yokochi, Lance A.
    Crawford, E. David
    O'Brien, Barbara
    Clapp, Jonathan D.
    Rathmell, Joshua M.
    Riley, Thomas L.
    Hayes, Richard B.
    Kramer, Barnett S.
    Izmirlian, Grant
    Miller, Anthony B.
    Pinsky, Paul F.
    Prorok, Philip C.
    Gohagan, John K.
    Berg, Christine D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) : 1310 - 1319
  • [3] [Anonymous], 2009, SEER Cancer Statistics Review, 1975-2006
  • [4] Radical prostatectomy versus watchful waiting in early prostate cancer
    Bill-Axelson, A
    Holmberg, L
    Ruutu, M
    Häggman, M
    Andersson, SO
    Bratell, S
    Spångberg, A
    Busch, C
    Nordling, S
    Garmo, H
    Palmgren, J
    Adami, HO
    Norlén, BJ
    Johansson, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) : 1977 - 1984
  • [5] Hereditary prostate cancer: Clinical aspects
    Bratt, O
    [J]. JOURNAL OF UROLOGY, 2002, 168 (03) : 906 - 913
  • [6] DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING
    CATALONA, WJ
    SMITH, DS
    RATLIFF, TL
    BASLER, JW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08): : 948 - 954
  • [7] Contemporary trends in low risk prostate cancer: Risk assessment and treatment
    Cooperberg, Matthew R.
    Broering, Jeannette M.
    Kantoff, Philip W.
    Carroll, Peter R.
    [J]. JOURNAL OF UROLOGY, 2007, 178 (03) : S14 - S19
  • [8] Vitamins E and C in the Prevention of Prostate and Total Cancer in Men The Physicians' Health Study II Randomized Controlled Trial
    Gaziano, J. Michael
    Glynn, Robert J.
    Christen, William G.
    Kurth, Tobias
    Belanger, Charlene
    MacFadyen, Jean
    Bubes, Vadim
    Manson, Joann E.
    Sesso, Howard D.
    Buring, Julie E.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (01): : 52 - 62
  • [9] HAMILTON RJ, 2008, N NATL CANC I, V100, P1487
  • [10] Use of 5α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline
    Kramer, Barnett S.
    Hagerty, Karen L.
    Justman, Stewart
    Somerfield, Mark R.
    Albertsen, Peter C.
    Blot, William J.
    Carter, H. Ballentine
    Costantino, Joseph P.
    Epstein, Jonathan I.
    Godley, Paul A.
    Harris, Russell P.
    Wilt, Timothy J.
    Wittes, Janet
    Zon, Robin
    Schellhammer, Paul
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04) : 1642 - 1657